The DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index.
The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer’s Disease
Open accessAbstract
There is accumulating evidence suggesting that changes in brain perfusion are present long before the clinical symptoms of Alzheimer's disease (AD), perhaps even before amyloid-β accumulation or brain atrophy. This evidence, consistent with the vascular hypothesis of AD, implicates cerebral blood flow (CBF) in the pathogenesis of AD and suggests its utility as a biomarker of preclinical AD. The extended preclinical phase of AD holds particular significance for disease modification, as treatment would likely be most effective in this early asymptomatic stage of disease. This highlights the importance of identifying reliable and accurate biomarkers of AD that can differentiate normal aging from preclinical AD prior to clinical symptom manifestation. Cerebral perfusion, as measured by arterial spin labeling magnetic resonance imaging (ASL-MRI), has been shown to distinguish between normal controls and adults with AD. In addition to demonstrating diagnostic utility, CBF has shown usefulness as a tool for identifying those who are at risk for AD and for predicting subtle cognitive decline and conversion to mild cognitive impairment and AD. Taken together, this evidence not only implicates CBF as a useful biomarker for tracking disease severity and progression, but also suggests that ASL-measured CBF may be useful for identifying candidates for future AD treatment trials, especially in the preclinical, asymptomatic phases of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · cited 2×
“2011), MCI (Albert et al. 2011), and preclinical AD (Sperling et al.”
BackgroundMethodCorder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
Biomarkers Definitions Working Group (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,771
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Greicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684
Research works printed but not linked: 1
- Sojkova, Goh, Beason-Held (2011) Increased beta-amyloid deposition is related to regional cerebral blood flow in nondemented older adults. In: Fifth Human Amyloid Imaging Conference, Miami
Cited by
Sorted by citations
Items 201–213 of 213
Abnormal cerebral blood flow in patients with Leber’s hereditary optic neuropathy
Wang, L., Ji, Y., Ding, H., Qin, T., Fan, K., Shi, D., Yu, C., & Qin, W. (2023) · Brain Imaging and Behavior · doi:10.1007/s11682-023-00775-5
Impact of physical activity on the development of Alzheimer's disease
Paśnik, J., Sendecka, G., Kistela, N., Hądzlik, I., Durowicz, M., & Piotrowski, J. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.71.51112 · Cited by 1
Jin, M., Liu, J., Bao, Z., Hong, X., He, S., & Gao, F. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5134427
El‐Ghazawi, K., Mills, W. A., Peirce, S. M., & Eyo, U. B. (2025) · Current Protocols · doi:10.1002/cpz1.70167
Urbinati, F., Bueno, J. A. R., Real, P. S., Redondo-López, M. C., Ortega, Á. S., García-Arnés, J. A., Gutiérrez‐Bedmar, M., Alba‐Linero, C., & García‐Casares, N. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251390894
Myoraku, A., Klein, G., Landau, S., & Tosun, D. (2022) · Figshare · doi:10.6084/m9.figshare.18585697
The Theoretical Intersection of Plant-Based Diets, Alzheimer’s, and Cardiovascular Disease
VanCleef, T. R., & Jones, E. J. (2026) · Biological Research For Nursing · doi:10.1177/10998004261439115
Rafiee, Z., Santiago, J., Andersson, E., Hansson, O., & Wennström, M. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1766448
Li, J., Yang, X., Liu, J. W., & Zhao, K. (2026) · The Cerebellum · doi:10.1007/s12311-026-02011-4
Skike, C. E. V., Miller, L. R., Hernandez, S. F., Hussong, S. A., Makhlouf, H., Muppala, A., DeRosa, N., Jahrling, J. B., Dineley, K. T., & Galván, V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.23.733858
Frontal and temporal hyper-perfusion in Parkinson's disease with subjective cognitive decline
Takeda, K., Shima, A., Nishida, A., Kambe, D., Furukawa, K., Sakamaki‐Tsukita, H., Yoshimura, K., Wada, I., Sakato, Y., Terada, Y., et al. (2026) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2026.108853
Gameiro, G. R., Hoover, A. H., Schor, P., Jiang, H., & Wang, J. (2026) · Translational Vision Science & Technology · doi:10.1167/tvst.15.8.7
Wang, J., Zhao, G., Lu, Q., Zhang, X., Piao, Z., Lin, A., Wang, S., Feng, Q., Wen, X., Qin, W., et al. (2026) · International Psychogeriatrics · doi:10.1016/j.inpsyc.2026.100304
Metadata
- Authors
- Hays, C. C., Zlatar, Z. Z., & Wierenga, C. E.
- Affiliations
- San Diego State University (US)
- University of California San Diego (US)
- Corresponding author
- Wierenga, Christina E.
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2016-02-22
- Volume
- 36
- Issue
- 2
- Pages
- 167-179
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- PMC
- PMC5278904
- OpenAlex
- W2283957277
- Cited by
- 213
- References
- 122
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 18 · 2023: 24 · 2022: 25 · 2021: 27 · 2020: 19 · 2019: 25 · 2018: 24 · 2017: 19 · 2016: 5
- Type
- book review
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cellular and Molecular Neurobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- VA CSR&D Merit Award (5I01CX000565)
- National Institutes of Health T32 (MH019934)
- National Science Foundation Graduate Research Fellowship Program (2015207525)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- cerebral blood flow, preclinical Alzheimer's disease, arterial spin labeling, cerebral perfusion, biomarkers, normal aging, mild cognitive impairment, cognitive decline prediction, disease progression
- MeSH terms
- Aging, Alzheimer Disease, Cerebrovascular Circulation, Humans, Risk Factors, Biomarkers, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
